Agoracom Blog Home

Author Archive

Novamind $NM.ca $NVMDF to Present at Benzinga Conference $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 12:08 PM on Tuesday, February 23rd, 2021
  • Announced its participation in the Benzinga Cannabis Capital Conference, on February 25th and 26th, 2021, one of the select companies to be featured from the emerging psychedelics industry.
  • On Friday, February 26th, 2021 at 1:30pm EST, Novamind’s CEO and Director, Yaron Conforti, will present the Company’s vision for scaling access to psychedelic medicine and advancing clinical research.

TORONTO, ON / February 23, 2021 / Novamind Inc. (CSE:NM) (OTC PINK:NVMDF) (“Novamind” or “the Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Benzinga Cannabis Capital Conference (“the Conference”), on February 25th and 26th, 2021, one of the select companies to be featured from the emerging psychedelics industry.

On Friday, February 26th, 2021 at 1:30pm EST, Novamind’s CEO and Director, Yaron Conforti, will present the Company’s vision for scaling access to psychedelic medicine and advancing clinical research.

“We are excited to connect with investors who share our belief that innovative mental health therapies are disrupting the current standard of care in mental health,” said Yaron Conforti, CEO and Director of Novamind. “I look forward to this opportunity to share Novamind’s approach to mental healthcare and clinical research in psychedelic medicine.”

The Conference will also host a panel discussion on psychedelics with industry leaders including Novamind’s Chief Medical Officer, Dr. Reid Robison on Friday, February 26th, 2021 at 1:50pm EST.

For more information about the conference, please click here.

About Novamind
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.

Contact Information:

Novamind
Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512

Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements
This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

SOURCE: Novamind Inc.

Spyder $SPDR.ca Cannabis to Acquire a Leading Vape Retailer 180 Smoke $ACB $APHA $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 11:23 AM on Tuesday, February 23rd, 2021
  • To acquire all of the issued and outstanding shares of the entities that collectively comprise the business of 180 Smoke (“180 Smoke“), a dominant vape retailer in Canada. The Company has agreed to purchase the shares of 180 Smoke

Vaughan, Ontario–(February 23, 2021) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“), an established Canadian cannabis and vape retailer, is pleased to announce that the Company has entered into a binding agreement with CRHC Holdings Corp. (the “Seller“) to acquire all of the issued and outstanding shares of the entities that collectively comprise the business of 180 Smoke (“180 Smoke“), a dominant vape retailer in Canada. The Company has agreed to purchase the shares of 180 Smoke (the “Acquisition“), on a cash-free basis (after post-closing adjustments), for nominal consideration. Additionally, the Company has secured a strategic institutional investor to acquire all of the existing debt of 180 Smoke owing to an affiliate of the Seller. The parties will proceed to close the Acquisition upon satisfaction of the closing conditions.

Transaction Highlights

  • 180 Smoke is a leading Canadian vape product retailer that has been widely regarded as the gold standard for vape store operations and customer service. 180 Smoke sells high-quality e-cigarettes, vaporizers and other nicotine-related products.
  • The Acquisition is expected to immediately increase Spyder’s consolidated revenue with the addition of 180 Smoke’s nicotine vape sales, franchise revenue and other wholesale and distribution revenue which generated approximately $12.9 million in unaudited net revenue during the year ended December 31, 2020.
  • 180 Smoke has a team of 91 employees who will continue to operate 180 Smoke’s 18 brick and mortar vape retail locations, 8 franchises, and its corporate head office and distribution warehouse, following the closing of the Acquisition.
  • 180 Smoke’s current customer base includes 92,481 in-store accounts, 98,052 online accounts, as well as 235 specialty wholesale vape B2B accounts.
  • Spyder expects to integrate its 2 brick and mortar vape retail stores with those of 180 Smoke’s to leverage the acquired know-how and intellectual property, including retail store design and layout, standard operating procedures, administrative systems and customer support, human resources and staff training, and accounting.
  • Synergies are also expected between 180 Smoke’s existing customer base with Spyder’s cannabis business.
  • Spyder will have the ability to utilize its wholly-owned subsidiary’s Retail Operator License issued by the Alcohol and Gaming Commission of Ontario (AGCO) to convert some of 180 Smoke’s existing vape retail locations to licensed cannabis dispensaries by obtaining a Retail Store Authorization from the AGCO for such store.

Read More: https://agoracom.com/ir/SpyderCannabis/forums/discussion/topics/755908-spyder-cannabis-to-acquire-a-leading-vape-retailer-180-smoke/messages/2304946#message

AGORACOM Welcomes PK Beans $BEAN.ca A Revenue Generating Female-Led Children’s Clothing Brand

Posted by AGORACOM-JC at 11:04 AM on Tuesday, February 23rd, 2021

A Revenue Generating Female-Led Children’s Clothing Brand

Why PK Beans

  • Award winning brand (Jillian Harris Favourite Brand)
  • $1.5M in 2020 Sales
  • 10,000 customers
  • 62% returning customer rate
  • 790 affiliates
  • Over 18K orders this year

Other KPI’s

  • Reported significant growth in its online presence:
  • August 2020 reported a 21% increase in online users and a 247% increase in web conversions; from 249 conversions in August 2019 to 1292 in 2020
  • Company saw a 292% increase in return on ad spend (ROAS) from 7x in August 2019 to 28x in August 2020.
  • Resulted in a 373% increase in revenue from ad spend, up from $25,668 to $121,425 in August 2019 and August 2020 respectively.
  • 900% increase of sales on Fall launch day over Fall 2019, of $36,000 and a 25% inventory sell through within the first two weeks
  • Launched reusable mask program for kids and families selling over 5,000 masks with a 50% gross margin bringing in revenue of $60k.

Clothing Line

BEAN-1

Outlook

  • Significant revenue and EBITDA growth projected in the next 12 months through marketing initiatives and profitability
  • Powerful low cost omni-channel distribution model that allows for exponential growth
  • Improving gross margins by reducing our costs through new manufacturing partnerships and product assortment, including our worn wear secondary revenue stream and short term revenue on mask sales
  • Significant Growth of the second hand market revenue
  • Establishing loyal customer base and revenue stream

Female Powered Team

Female-Powered-Team

Promotional Programs

PKB Explorers Club

  • Introduced the adventure subscription box “PKB Explorers Club”
  • Monthly subscription that will extend the Company’s retail apparel brand into children adventure play and media space.
  • Will enhance the brand and convert the steps taken in marketing into a profitable recurring revenue stream
PK Beans brings a kids club for education and entertainment straight to the  home - InvestorIntel
  • PK  Explorers’  Club  allows  children  to  become  immersed  into  a  magical  storybook  world, conceived  by  Emmy-winning  child  psychologists. 
  • Each  month,  children  receive  a  new  storybook,  with Augmented Reality (AR) components for a balanced digital engagement. In addition, with AR, it includes active  play  components,  such  as  a  dress-up  felt  board  and  an  adventure  map.
GDFA Season Pass Subscription – PKB Explorers' Club


PK Replay

https://cdn.shopify.com/s/files/1/0015/7322/4559/files/PK-RePlay-webpage-bar_0718c8dc-9f67-465c-95d0-c78703163dcf.jpg?v=1587066768
  • Launched a sustainability initiative in store, and online,  also known as a second hand  resale  program called, PK REPLAY. 
  • Provides a 56% margin and repurposed items boast an 86% gross margin for the Company
  • With the high quality and longevity of PK Beans clothing, being able to offer good quality second hand pieces is perfect for reaching new and long standing customers.
  • Meanwhile this will keep clothing out of landfills and having a positive impact on the environment.
  • An economic and environmentally new opportunity for the Company as there is rapid growth in the second hand retail appeal market

 Manufacturing

OEKO
  • The fabric that PK Beans designs in-house for its playwear apparel are third-party tested to guarantee that it is aligned with OEKO-TEK® Standard 100, an independent testing and certification system for all stages of production from textile raw materials to end products. 
  • The requirement is that all components of an item  comply  with  the  required  criteria  without  exception,  including  the  outer  material,  sewing  threads, linings, prints, etc., as well as non-textile accessories such as buttons, zip fasteners, rivets, etc. for harmful substances and sensitivity to skin contact. 
  • In addition, PK Beans conducts its own third-party lab testing to ensure its dying mills are adhering to the Company’s standards that its fabric does not contain harmful levels of heavy metals and other harsh additives that are found in most children’s clothing fabrics and dyes. 
  • PK Beans works closely with its third-party contract manufacturers who adhere to a vendor code of ethics regarding social and environmental sustainability  practices.  
  • PK  Beans relies  on  a  limited  number  of  suppliers  to  provide  custom  designed fabrics and follows the production of its apparel from raw fiber to finished garment.

Kontrol $KNR $KNR.ca $KNR.c $KNRLF to provide BioCloud Field Demonstration and Customer application access $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 9:09 AM on Tuesday, February 23rd, 2021
  • On a case-by-case basis and subject to the required customer approval the Company will provide video access and any relevant operating data.
  • “We understand the value and importance of sharing BioCloud units in operation across various customer applications,” says Paul Ghezzi, CEO of Kontrol.

TORONTO, ON / February 23, 2021 / Kontrol Technologies Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“) is pleased to announce that it plans to provide real-time demonstration of BioCloud units in operation in various customer and/or pilot customer (“customer”) applications. On a case-by-case basis and subject to the required customer approval the Company will provide video access and any relevant operating data.

“We understand the value and importance of sharing BioCloud units in operation across various customer applications,” says Paul Ghezzi, CEO of Kontrol. “To the extent that we have customer approval we will also share operating data with respect to specific applications. Where we are unable to provide specific operating access to a customer application, we will seek to aggregate and showcase that data in a manner which meets any privacy constraints.”

The Company will work with its customers to share photos and videos of the BioCloud units in operation and share that content. In certain cases, a customer pilot may be restricted from being shared based on the customer’s requirements for non-disclosure. Over the coming weeks the Company anticipates sharing multiple demonstrations of BioCloud in operation.

Production Improvement

The Company has been working with its contract manufacturing partners to enhance the production design of BioCloud with a specific emphasis on reducing the number of circuit boards. The number of circuit boards has been reduced to 5 starting from an initial prototype design of 11. These improvements are considered part of the normal course of moving from prototype to scale production. The reduction in circuit boards will also provide an opportunity to lower manufacturing costs in the future.

Update to Distribution Model

The Company currently has 11 total distributors and 3 sales referral agreements. The sales referral agreements relate to the China and Middle East markets. The sales referral agreements are non-exclusive in nature. The Company has chosen to limit the number of Canadian non-exclusive distribution agreements, from its original plans, given its view that the Canadian market has sufficient distributors in place. The Company is currently negotiating multiple new potential agreements for the USA and the Middle East on a non-exclusive basis.

Read More: https://agoracom.com/ir/KontrolTechnologies/forums/discussion/topics/755883-kontrol-to-provide-biocloud-field-demonstration-and-customer-application-access/messages/2304893#message

POET Technologies $PTK.ca $POETF Targets New Markets for Co-Packaged Optics and Optical Sensing Applications with LightBar-C™ Product

Posted by AGORACOM-JC at 9:00 AM on Tuesday, February 23rd, 2021
  • Extended the Optical Interposer into new applications and markets with a fully-integrated, multiplexed light-source for optical computing chipsets and sensing applications, named “ LightBar-C™”.

TORONTO, Feb. 23, 2021 — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, announced that it has extended the Optical Interposer into new applications and markets with a fully-integrated, multiplexed light-source for optical computing chipsets and sensing applications, named “ LightBar-C™”.

The POET Optical Interposer platform has been extended and validated with the intrinsic features to support Conventional Band (“C-band”) and Long Band (“L-band”) lasers that produce light in a frequency range of 1530nm to 1625nm. POET has designed, developed and demonstrated cooled lasers for the Optical Interposer platform with up to 90mW of power operating at room temperature. In addition, the Company has designed and demonstrated a Dense Wavelength Division Multiplexer (“DWDM”) embedded in the Optical Interposer waveguide layer that allows channel spacings of 200GHz, providing the high density and broadband requirements needed for high-performance optical sensing and Co-Packaged Optics (CPO) applications, such as optical computing chipsets for Artificial Intelligence.

The Company’s first product to incorporate all of these features is the POET LightBar-C, which includes integrated spot-size converters that minimize coupling losses and increase power efficiency of components, such as multiplexers and detectors. The product provides low-loss fiber and free-space coupling, all specifically developed for highly integrated solutions within the C-band frequencies. The LightBar-C also utilizes a versatile and integrated laser source with multiple wavelengths (from 2 up to 8) multiplexed in the C-Band.

The optical bandwidth in the C-band is in the “eye-safe” region, which makes it ideal for free-space sensing applications. Consequently, C-band light solutions are expected to be foundational to the next generation of LiDAR solutions where high sensitivity, high power, reduced atmospheric influence and eye safety are presumed to be essential requirements.

Read More: https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/755882-poet-technologies-targets-new-markets-for-co-packaged-optics-and-optical-sensing-applications-with-lightbar-c-product/messages/2304892#message

VIDEO – American Creek Spins Out Stinger Resources; Shareholders Own 2 Public Companies as Maiden Treaty Creek Resource Approaches $STNG.ca $TUD.ca $ESK.ca $SEA.ca $STNG.ca

Posted by AGORACOM-JC at 8:10 AM on Tuesday, February 23rd, 2021
American Creek Provides Update on Its First Quarter Filings

American Creek owns 20% of Treaty Creek, a project that is currently waiting on a maiden resource and estimated to be around 30 million ounces. It’s safe to assume if your flagship asset is within the scale of a world class asset such as Treaty Creek, your supporting assets are not being recognized for their value. This is where Stinger (STNG: TSXV) comes in. All non-core AMK assets are now the property of Stinger, including millions in cash and over 1m Tudor Gold shares. American Creek keeps the 20% carried Interest to production at Treaty Creek, and any future discoveries. Oh, and the very first Resource at Treaty Creek

2 Companies. 1 Bull Market. Sit back and have a listen to this great interview with Kelvin Burton as he explains for all shareholders, AMK and soon to be STNG.

PyroGenesis $PYR.ca CEO to Present at the 7th Annual Gabelli & Company Waste & Environmental Services Symposium on March 18 $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 10:52 AM on Monday, February 22nd, 2021
  • Announced today that Mr. P. Peter Pascali, CEO and Chair of PyroGenesis, has been invited to present at the prestigious 7 th Annual Gabelli & Company Waste Services Symposium being held virtually on Thursday, March 18th. Mr. Pascali will be presenting at 1:45pm ET.

MONTREAL, Feb. 22, 2021 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that Mr. P. Peter Pascali, CEO and Chair of PyroGenesis, has been invited to present at the prestigious 7 th Annual Gabelli & Company Waste Services Symposium being held virtually on Thursday, March 18th. Mr. Pascali will be presenting at 1:45pm ET.

“It is indeed an honor to be asked again to present at this distinguished conference,” said Mr. P. Peter Pascali, CEO & Chair of PyroGenesis. “I look forward to the event, and presenting to both existing and prospective investors, as well as to members of the environmental services industry.”

For anyone interested in attending, please register through the following link: https://gabelli.zoom.us/webinar/register/WN_4EMucHySQOeORDE4Omw8dg .

Read More: https://agoracom.com/ir/PyroGenesisCanada/forums/discussion/topics/755801-pyrogenesis-ceo-to-present-at-the-7th-annual-gabelli-company-waste-environmental-services-symposium-on-march-18/messages/2304714#message

POET Technologies $PTK.ca $POETF Provides Highlights and Results of Special Meeting

Posted by AGORACOM-JC at 10:35 AM on Monday, February 22nd, 2021
  • Announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.
  • Authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.

TORONTO, Feb. 22, 2021 – POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.

The Company’s Chairman and Chief Executive Officer, Dr. Suresh Venkatesan, conducted the formal business of the Meeting, which focused solely on seeking authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.

Read More: https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/755798-poet-technologies-provides-highlights-and-results-of-special-meeting/messages/2304711#message

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Establishes Scientific Advisory Board for BioCloud Technology $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 10:21 AM on Monday, February 22nd, 2021
  • Announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.
  • “Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol.

TORONTO, ON / February 22, 2021 / Kontrol Technologies Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“) is pleased to announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.

“Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol. “Vaccines are integral to a broader recovery, however more technology is required for detection and monitoring. We are pleased to be taking a leadership role in this new industry of real-time viral detection infrastructure. Our technology was developed for the current pandemic and the pandemics of the future.”

“We are very pleased to establish a world class advisory board for Kontrol BioCloud,” says Gary Saunders, VP Kontrol. “Our advisory board members are at the top of their field and their counsel will be very important to the future of Kontrol BioCloud and other innovative applications of the technology we may seek to develop.”

Read More: https://agoracom.com/ir/KontrolTechnologies/forums/discussion/topics/755793-kontrol-establishes-scientific-advisory-board-for-biocloud-technology/messages/2304704#message

Else Nutrition $BABY.ca $BABYF has Developed a Breakthrough, Patent-Pending Clean Processing of Ingredients for its Infant Formula $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 9:53 AM on Monday, February 22nd, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Else has developed a breakthrough, proprietary process to further ensure the safety of the formula.
  • This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

VANCOUVER, BC , Feb. 22, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , announces as part of its progress towards commercializing a clean label, dairy-free and soy-free, plant-based infant formula, Else has developed a breakthrough, proprietary process to further ensure the safety of the formula. This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

This new process builds on the company’s already clean and most natural production process that ensures the highest quality standards – it does not use harsh chemicals or detergents (commonly used in the industry) and does not impact the formula’s amino acids or other macronutrients.

“The World Health Organization considers the first 1000 days of life as critically important to long term health and wellness. It’s the window of time where optimum brain and immune system development is established. Infant formula is the exclusive form of nourishment for many babies during this critical period of development. The recent consumer and regulatory call to action is especially prudent to the formula category. Else Nutrition is voluntarily and proactively changing the way they source ingredients, manufacture their products, and think about food safety all in an effort to optimize environmental and public health now and into the future,” said Jaclyn Bowen MPH, MS food and consumer products safety and systems engineer and Executive Director of Clean Label Project.

“We’re leading a clean revolution, disrupting the baby food industry by setting a new standard in quality, transparency and sustainability. This latest development brings us even closer to bringing clean label, plant-based, minimally processed infant formula to wanting parents worldwide,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition.

The novel pre-process was under development for nearly a year. A full Pilot stage was successfully completed and tested recently at the company’s innovation center in Northern Israel , positively demonstrating reduction of specific elements levels.

Already a recipient of The Clean Label Project’s Purity Award (an honor only bestowed after products are tested for over 400 contaminants and heavy metals and meet the organization’s highest standard) for its Plant-Based Complete Nutrition for Toddlers product, Else continues its commitment to ‘cleaning up’ the baby/toddler nutrition aisles with safe, clean label products of the highest quality.

Else is proud to share this exciting development and its continued commitment to baby food safety and quality, in light of a recent congressional report that revealed that many baby food products offered by leading manufacturers contain significant levels of toxic heavy metals.

Else’s ‘Beyond Organic’ Processing

Else Nutrition is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that provides the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients. It is made using a clean, most natural and sustainable industry process.

Read More: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/755787-else-nutrition-has-developed-a-breakthrough-patent-pending-clean-processing-of-ingredients-for-its-infant-formula/messages/2304698#message